ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Glaxosmithkline Us Trading Limited

Glaxosmithkline Us Trading Limited is an active company incorporated on 12 September 2018 with the registered office located in London, Greater London. Glaxosmithkline Us Trading Limited was registered 7 years ago.
Status
Active
Active since incorporation
Company No
11566030
Private limited company
Age
7 years
Incorporated 12 September 2018
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 29 September 2025 (1 month ago)
Next confirmation dated 29 September 2026
Due by 13 October 2026 (11 months remaining)
No changes occurred since incorporation
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
79 New Oxford Street
London
WC1A 1DG
United Kingdom
Address changed on 23 Sep 2024 (1 year 1 month ago)
Previous address was
Telephone
020 80475000
Email
Unreported
Website
People
Officers
11
Shareholders
1
Controllers (PSC)
1
Director • Director • VP Primary And Small Molecules • British • Lives in UK • Born in Sep 1966
Director • British • Lives in UK • Born in Jul 1976
Director • British • Lives in UK • Born in Mar 1963
Director • Managing Director • Irish • Lives in Ireland • Born in Feb 1964
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Glaxosmithkline Trading Services Limited
Edinburgh Pharmaceutical Industries Limited, Mark James Heathcote, and 5 more are mutual people.
Active
Glaxosmithkline Export Limited
Aidan Lynch, Wendy Adams, and 2 more are mutual people.
Active
Glaxosmithkline Intellectual Property Management Limited
Edinburgh Pharmaceutical Industries Limited and are mutual people.
Active
Glaxosmithkline Intellectual Property (No.3) Limited
Edinburgh Pharmaceutical Industries Limited and are mutual people.
Active
Glaxosmithkline Intellectual Property (No.4) Limited
Edinburgh Pharmaceutical Industries Limited and are mutual people.
Active
Eskaylab Limited
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Smithkline Beecham Legacy H Limited
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Glaxosmithkline Finance Plc
The Wellcome Foundation Limited and Edinburgh Pharmaceutical Industries Limited are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Decreased by £1.47M (-100%)
Turnover
£815.43M
Increased by £239.93M (+42%)
Employees
Unreported
Same as previous period
Total Assets
£192.07M
Increased by £45.17M (+31%)
Total Liabilities
-£165.02M
Increased by £38.6M (+31%)
Net Assets
£27.05M
Increased by £6.57M (+32%)
Debt Ratio (%)
86%
Decreased by 0.14% (-0%)
Latest Activity
Confirmation Submitted
1 Month Ago on 29 Sep 2025
Andrew James Collier Resigned
2 Months Ago on 11 Aug 2025
Edinburgh Pharmaceutical Industries Limited Resigned
2 Months Ago on 11 Aug 2025
Neil Richard Wilkinson Resigned
2 Months Ago on 11 Aug 2025
Yvonne Margaret Stewart Resigned
2 Months Ago on 11 Aug 2025
Mark James Heathcote Resigned
2 Months Ago on 11 Aug 2025
Full Accounts Submitted
3 Months Ago on 10 Jul 2025
Andrew James Collier Appointed
10 Months Ago on 1 Jan 2025
Wendy Adams Resigned
10 Months Ago on 31 Dec 2024
Mr Neil Richard Wilkinson Appointed
1 Year Ago on 1 Nov 2024
Get Credit Report
Discover Glaxosmithkline Us Trading Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 29 September 2025 with no updates
Submitted on 29 Sep 2025
Termination of appointment of Andrew James Collier as a director on 11 August 2025
Submitted on 21 Aug 2025
Termination of appointment of Mark James Heathcote as a director on 11 August 2025
Submitted on 20 Aug 2025
Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 11 August 2025
Submitted on 20 Aug 2025
Termination of appointment of Yvonne Margaret Stewart as a director on 11 August 2025
Submitted on 20 Aug 2025
Termination of appointment of Neil Richard Wilkinson as a director on 11 August 2025
Submitted on 20 Aug 2025
Full accounts made up to 31 December 2024
Submitted on 10 Jul 2025
Appointment of Andrew James Collier as a director on 1 January 2025
Submitted on 14 Jan 2025
Termination of appointment of Wendy Adams as a director on 31 December 2024
Submitted on 7 Jan 2025
Appointment of Mr Neil Richard Wilkinson as a director on 1 November 2024
Submitted on 4 Nov 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year